- $2.92bn
- $3.97bn
- $2.38bn
- 88
- 61
- 57
- 79
Annual income statement for ICU Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,271 | 1,316 | 2,280 | 2,259 | 2,382 |
| Cost of Revenue | |||||
| Gross Profit | 461 | 491 | 698 | 740 | 825 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,173 | 1,193 | 2,323 | 2,236 | 2,339 |
| Operating Profit | 98.2 | 123 | -42.9 | 22.8 | 43 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 97.5 | 123 | -114 | -78.3 | -66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 86.9 | 103 | -74.3 | -29.7 | -118 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 86.9 | 103 | -74.3 | -29.7 | -118 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 86.9 | 103 | -74.3 | -29.7 | -118 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.08 | 5.5 | -1.1 | -0.114 | -3.19 |